GB virus C coinfections in west African Ebola patients
- PMID: 25473056
- PMCID: PMC4338908
- DOI: 10.1128/JVI.02752-14
GB virus C coinfections in west African Ebola patients
Abstract
In 49 patients with known Ebola virus disease outcomes during the ongoing outbreak in Sierra Leone, 13 were coinfected with the immunomodulatory pegivirus GB virus C (GBV-C). Fifty-three percent of these GBV-C(+) patients survived; in contrast, only 22% of GBV-C(-) patients survived. Both survival and GBV-C status were associated with age, with older patients having lower survival rates and intermediate-age patients (21 to 45 years) having the highest rate of GBV-C infection. Understanding the separate and combined effects of GBV-C and age on Ebola virus survival may lead to new treatment and prevention strategies, perhaps through age-related pathways of immune activation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures
Similar articles
-
[GBV-C infection in HIV-infected patients in the Russian Federation].Vopr Virusol. 2010 Jan-Feb;55(1):23-6. Vopr Virusol. 2010. PMID: 20364667 Russian.
-
Epidemiology of GB virus type C among patients infected with HIV in Singapore.J Med Virol. 2014 May;86(5):737-44. doi: 10.1002/jmv.23893. Epub 2014 Jan 31. J Med Virol. 2014. PMID: 24481554
-
High prevalence of GB virus C/hepatitis G virus genotype 3 among autochthonous Venezuelan populations.J Med Virol. 2002 Nov;68(3):357-62. doi: 10.1002/jmv.10211. J Med Virol. 2002. PMID: 12226822
-
[Molecular biology of GBV-C/HGV].Nihon Rinsho. 2004 Aug;62 Suppl 8:577-81. Nihon Rinsho. 2004. PMID: 15453386 Review. Japanese. No abstract available.
-
Detection of GB virus C genomic sequence in the cerebrospinal fluid of a HIV-infected patient in China: a case report and literature review.Epidemiol Infect. 2016 Jan;144(1):106-12. doi: 10.1017/S0950268815001326. Epub 2015 Jun 17. Epidemiol Infect. 2016. PMID: 26081197 Free PMC article. Review.
Cited by
-
Molecular characterization and frequency of human pegivirus type 1 (HPgV-1) in kidney transplant recipients from Central-West Brazil.Braz J Microbiol. 2024 Aug 21. doi: 10.1007/s42770-024-01490-z. Online ahead of print. Braz J Microbiol. 2024. PMID: 39164460
-
Genome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever.Nat Microbiol. 2024 Mar;9(3):751-762. doi: 10.1038/s41564-023-01589-3. Epub 2024 Feb 7. Nat Microbiol. 2024. PMID: 38326571 Free PMC article.
-
Investigating the etiologies of non-malarial febrile illness in Senegal using metagenomic sequencing.Nat Commun. 2024 Jan 25;15(1):747. doi: 10.1038/s41467-024-44800-7. Nat Commun. 2024. PMID: 38272885 Free PMC article.
-
Microbial transmission in the social microbiome and host health and disease.Cell. 2024 Jan 4;187(1):17-43. doi: 10.1016/j.cell.2023.12.014. Cell. 2024. PMID: 38181740 Free PMC article. Review.
-
Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria.Nat Commun. 2023 Aug 4;14(1):4693. doi: 10.1038/s41467-023-40247-4. Nat Commun. 2023. PMID: 37542071 Free PMC article.
References
-
- World Health Organization. 14November2014. Ebola response roadmap—situation report update. World Health Organization, Geneva, Switzerland: http://www.who.int/csr/disease/ebola/situation-reports/en/.
-
- Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, Saffa S, Sellu J, Jalloh AA, Kovoma A, Koninga J, Mustapha I, Kargbo K, Foday M, Yillah M, Kanneh F, Robert W, Massally JL, Chapman SB, Bochicchio J, Murphy C, Nusbaum C, Young S, Birren BW, Grant DS, Scheiffelin JS, Lander ES, Happi C, Gevao SM, Gnirke A, Rambaut A, Garry RF, Khan SH, Sabeti PC. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345:1369–1372. doi:10.1126/science.1259657. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
- C06 RR020141/RR/NCRR NIH HHS/United States
- C06 RR015459/RR/NCRR NIH HHS/United States
- P51 RR000167/RR/NCRR NIH HHS/United States
- RR15459-01/RR/NCRR NIH HHS/United States
- T32 GM081061/GM/NIGMS NIH HHS/United States
- RR020141-01/RR/NCRR NIH HHS/United States
- R01 AI077376-01/AI/NIAID NIH HHS/United States
- R01AI077376/AI/NIAID NIH HHS/United States
- R01 AI077376/AI/NIAID NIH HHS/United States
- P51RR000167/RR/NCRR NIH HHS/United States
- T32 GM008692/GM/NIGMS NIH HHS/United States
- T32 AI055397/AI/NIAID NIH HHS/United States
- R01 AI098420/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical